Literature DB >> 2193311

Sexual performance of old and young male rhesus macaques following treatment with GnRH.

C H Phoenix1, K C Chambers.   

Abstract

GnRH has been reported to facilitate sexual performance in a number of species. To determine whether the same was true for rhesus monkeys we measured sexual behavior and serum levels of testosterone (T) and luteinizing hormone (LH) following control tests and after treatment with two doses of GnRH. In the first experiment, old intact (N = 11) and old T-implanted, castrated (N = 4) rhesus macaques were examined. Mean intromission rate of old intact males was significantly lower following treatment with 100 micrograms of GnRH than following control injections. Other measures of sexual behavior did not differ across treatments. There were no significant treatment effects among the old castrated males. The failure to facilitate sexual performance may have been due to the age of the males and not to the species under study. Thus, in a second experiment the effects of GnRH were examined in young rhesus males. Again, there was no facilitation of sexual performance. This cannot be accounted for by a failure of GnRH to produce a physiological response. For both old and young intact males serum levels of LH and T increased significantly after treatment with both doses of GnRH. LH but not T levels increased significantly in the T-implanted males.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2193311     DOI: 10.1016/0031-9384(90)90118-n

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  6 in total

1.  Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma.

Authors:  Tan-Huy Chu; Manh-Cuong Vo; Hye-Seong Park; Thangaraj Jaya Lakshmi; Sung-Hoon Jung; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Cancer Immunol Immunother       Date:  2020-07-04       Impact factor: 6.968

2.  Selective enhancement of main olfactory input to the medial amygdala by GnRH.

Authors:  Camille Bond Blake; Michael Meredith
Journal:  Brain Res       Date:  2009-12-22       Impact factor: 3.252

Review 3.  Advances in targeted therapy for malignant lymphoma.

Authors:  Li Wang; Wei Qin; Yu-Jia Huo; Xiao Li; Qing Shi; John E J Rasko; Anne Janin; Wei-Li Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-03-06

Review 4.  Glucocorticoids and immune checkpoint inhibitors in glioblastoma.

Authors:  William J Kelly; Mark R Gilbert
Journal:  J Neurooncol       Date:  2020-02-27       Impact factor: 4.130

5.  The CC' loop of IgV domains of the immune checkpoint receptors, plays a key role in receptor:ligand affinity modulation.

Authors:  Shankar V Kundapura; Udupi A Ramagopal
Journal:  Sci Rep       Date:  2019-12-16       Impact factor: 4.379

6.  Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1.

Authors:  Jang-June Park; Emily P Thi; Victor H Carpio; Yingzhi Bi; Andrew G Cole; Bruce D Dorsey; Kristi Fan; Troy Harasym; Christina L Iott; Salam Kadhim; Jin Hyang Kim; Amy C H Lee; Duyan Nguyen; Bhavna S Paratala; Ruiqing Qiu; Andre White; Damodharan Lakshminarasimhan; Christopher Leo; Robert K Suto; Rene Rijnbrand; Sunny Tang; Michael J Sofia; Chris B Moore
Journal:  Nat Commun       Date:  2021-02-22       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.